Literature DB >> 29576192

Improved Cardiovascular Risk Factors Control Associated with a Large-Scale Population Management Program Among Diabetes Patients.

Jamal S Rana1, Andrew J Karter2, Jennifer Y Liu3, Howard H Moffet3, Marc G Jaffe4.   

Abstract

BACKGROUND: Optimal cardiovascular risk factors control among individuals with diabetes remains a challenge. We evaluated changes in glucose, lipid, and blood pressure control among diabetes patients after implementation of a large-scale population management program, known as Preventing Heart Attacks and Strokes Everyday, at Kaiser Permanente Northern California (KPNC), during 2004-2013.
METHODS: We used National Committee for Quality Assurance Healthcare Effectiveness Data and Information Set cut points to identify prevalence of poor glycemic (hemoglobin A1c > 9%) control, good lipid control (low-density lipoprotein cholesterol < 100 mg/dL), and good blood pressure control (blood pressure < 140/90 mm Hg) in each year (N range = 98,345 to 122,177 over the entire period). We assessed trends in risk factor control based on Joinpoint regression and average annual percentage change (AAPC) compared with published National Committee for Quality Assurance Healthcare Effectiveness Data and Information Set commercial rates.
RESULTS: We found that the prevalence of poor glycemic control (hemoglobin A1c > 9%) declined in both KPNC and nationally, but was statistically significant only in KPNC (AAPC = -4.8; P < .05). The prevalence of good lipid control (low-density lipoprotein cholesterol < 100 mg/dL) increased significantly in KPNC (47% to 71%; AAPC = +4.3; P < .05), but there was no significant improvement nationally (40% to 44%; AAPC = +1.4; P = .2). The prevalence of blood pressure control (<140/90 mm Hg) was higher in KPNC (77% to 82%; AAPC = +1.1; P < .05) versus nationally (57% to 62%; AAPC = +1.9; P < .05) during the reported years 2007-2013.
CONCLUSIONS: Relative to national benchmarks, a substantially greater improvement in risk factor control among adults with diabetes was observed after implementation of a comprehensive population management program.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Diabetes mellitus; Managed care programs; Risk factors

Mesh:

Substances:

Year:  2018        PMID: 29576192     DOI: 10.1016/j.amjmed.2018.01.024

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  5 in total

1.  Initial Glycemic Control and Care Among Younger Adults Diagnosed With Type 2 Diabetes.

Authors:  Anjali Gopalan; Pranita Mishra; Stacey E Alexeeff; Maruta A Blatchins; Eileen Kim; Alan Man; Andrew J Karter; Richard W Grant
Journal:  Diabetes Care       Date:  2020-03-04       Impact factor: 19.112

Review 2.  The Diabetic Cardiorenal Nexus.

Authors:  John A D'Elia; George P Bayliss; Larry A Weinrauch
Journal:  Int J Mol Sci       Date:  2022-07-01       Impact factor: 6.208

3.  Association Between High-Deductible Health Plans and Engagement in Routine Medical Care for Type 2 Diabetes in a Privately Insured Population: A Propensity Score-Matched Study.

Authors:  You M Wu; Jie Huang; Mary E Reed
Journal:  Diabetes Care       Date:  2022-05-01       Impact factor: 17.152

4.  Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study.

Authors:  Marilyn L Kwan; Richard K Cheng; Carlos Iribarren; Romain Neugebauer; Jamal S Rana; Mai Nguyen-Huynh; Zaixing Shi; Cecile A Laurent; Valerie S Lee; Janise M Roh; Hanjie Shen; Eileen Rillamas-Sun; Margarita Santiago-Torres; Dawn L Hershman; Lawrence H Kushi; Heather Greenlee
Journal:  J Clin Oncol       Date:  2022-01-13       Impact factor: 50.717

5.  Cumulative Adherence to Secondary Prevention Guidelines and Mortality After Acute Myocardial Infarction.

Authors:  Matthew D Solomon; Thomas K Leong; Eleanor Levin; Jamal S Rana; Marc G Jaffe; Stephen Sidney; Sue Hee Sung; Catherine Lee; Anthony DeMaria; Alan S Go
Journal:  J Am Heart Assoc       Date:  2020-03-05       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.